Dermira, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs on animals to assess a product’s safety profile.
In the following press release, the company announced the results of skin deposition study of DRM01 program when applied on animals.
“In this study, a topical gel formulation containing DRM01 at a concentration of 0% (representing the vehicle only), 4% or 7.5% was applied once or twice daily to the ears of Yorkshire pigs for seven days. ” Read the full article.
Dermira, Inc. is a biopharmaceutical company that focuses on bringing differentiated products to dermatologists and patients. It also focuses on medical dermatology, a field that concentrates on therapeutic solutions to treat skin conditions, such as psoriasis, hyperhidrosis and acne. Dermira was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA. [Source: MarketWatch]
Company Website: https://dermira.com